Samjin Pharmaceutical Trains Staff as Dementia Partners in Awareness Push in Awareness Push

Company Pursues "Dementia-Friendly Leading Company" Certification Training Held at Mapo-gu Dementia Care Center

Technology|
|
By Park Hong-yongprodigy@sedaily.com
||
Samjin Pharmaceutical dementia partner training program. Photo courtesy of Samjin Pharmaceutical - Seoul Economic Daily Technology News from South Korea
Samjin Pharmaceutical dementia partner training program. Photo courtesy of Samjin Pharmaceutical

Samjin Pharmaceutical said it will help raise employees' understanding of dementia and support building a community where patients and their families can live with peace of mind.

The company said it held "Dementia Partner" training for employees on the 21st at the auditorium of its headquarters in Seogyo-dong, Mapo-gu, Seoul. The program was organized by the Mapo-gu Dementia Care Center.

The training was aimed at meeting the requirements for "Dementia-Friendly Leading Company" certification. Through the certification, Samjin Pharmaceutical plans to help improve public awareness of dementia and contribute to creating a community environment where patients and their families can live with peace of mind.

The "Dementia-Friendly Leading Company" certification is part of the national dementia management program run by the Central Dementia Center under the Ministry of Health and Welfare. It is granted to companies that contribute to building a dementia-friendly environment by having employees complete "Dementia Partner" training and by using their infrastructure.

Through the training, employees learned about the definition, causes and prevention of dementia, as well as how to communicate properly with dementia patients. They came to see dementia as an issue that can be encountered in daily life and broadened their shared understanding of the need for a dementia-friendly environment.

Having met the certification requirements through the training, Samjin Pharmaceutical plans to continue joining efforts to build a community safety net for dementia by working with the dementia care center.

"With the number of dementia patients in Korea projected to exceed 1 million, dementia is no longer a problem for a particular individual or family but a pressing challenge that our entire society must respond to together," Samjin Pharmaceutical President Kim Sang-jin said. "Using this certification drive as a starting point, we will continue our social contribution activities to fulfill our social responsibility and values as a pharmaceutical company, alongside supplying quality treatments."

Original reporting by Park Hong-yong for Seoul Economic Daily.

AI-translated from Korean. Quotes from foreign sources are based on Korean-language reports and may not reflect exact original wording.

Watch · Seoul Economic Daily

More →
3:12

AI KEY

Preview
Korean Corporate Intelligence HubKOSPI · KOSDAQ · 12 sectors

A live, cap-weighted view of every KOSPI and KOSDAQ sector, with same-day Korean reporting distilled by company — built for foreign investors, correspondents and analysts who need to scan Korea before the next session.

Korea Company Atlas

Preview
Market Ontology · The Feedback LoopKFTC 2025 · 92 groups · 121,954 articles

An English ontology of the Korean market — how companies, the media, the government and the National Assembly move each other in a loop. Korea's named controlling persons and designated business groups are a mechanism, not a risk to be priced blind.

SIGNAL

Now live
English Edition · Capital MarketsM&A · IPO · PE · Fund Flows

SIGNAL English Edition is live — Korea's deal desk reporting in English. M&A, IPOs, private equity and fund flows, covered daily for global institutional investors. Browse free; subscriber-only scoops at the 50% intro rate.